ATS Clinical Practice Guidelines & Statements

• Diagnosis of IPF: An Official ATS/ERS/JRS/ALAT Guideline (2018)
• Executive Summary
• Full-Length Version
• Online Supplement
• Lymphangioleiomyomatosis Diagnosis and Management Part II: An Official ATS/JRS Clinical Practice Guideline (2017)
• Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis: An Official ATS Workshop Report (2017)
• Lymphangioleiomyomatosis Diagnosis and Management Part I: An Official ATS/JRS Clinical Practice Guideline (2016)
• Future Directions in Lung Fibrosis Research: An Official ATS Research Statement (2016)
• Interstitial Pneumonia with Autoimmune Features: An ATS/ERS Research Statement (2015)
• Treatment of IPF: An Official ATS/ERS/JRS/ALAT Guideline (2015)
• Executive Summary
• Full-Length Version
• Evidence Tables
• Evidence-to-Decision Tables
• Field Walking Tests in Chronic Respiratory Disease: Official ATS/ERS Technical Standards (2014)
• Measurement Properties of Field walking Tests in Chronic Respiratory Disease: An Official ATS/ERS Systematic Review (2014)
• Online Supplement
• The Choosing Wisely Top 5 List in Adult Pulmonary Medicine: An Official ATS/ACCP Statement (2014)
• Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias: An Official ATS/ERS Statement (2013)
• The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis In Interstitial Lung Disease: An Official ATS Clinical Practice Guideline (2012)
• The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis In Interstitial Lung Disease: An Official ATS Clinical Practice Guideline (2012) - Online Supplement
• Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management: An Official ATS/ERS/JRS/ALAT Statement (2011)
• NIH/NHLBI Notice re: 3-drug Regimen for IPF (2011)

ATS Patient Information Series Fact Sheets

• Idiopathic Pulmonary Fibrosis (IPF) 2017
  English
• Interstitial Lung Disease in Children 2015
  English |   Italian  |  Portuguese

ATS Clinical Practice Guideline Implementation ToolsFor: Diagnosis of IPF: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

• Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of idiopathic pulmonary fibrosis: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198(5):e44-e68.
• Executive Summary
• Full-Length Version
• Online Supplement
• Thomson CC, Duggal A, Bice T, Lederer DJ, Wilson KC, Raghu G.  2018 clinical practice guideline summary for clinicians: diagnosis of idiopathic pulmonary fibrosis. Ann Am Thorac Soc 2019;16(3): 285-290.
• CME Course and Exam (Expires March 2021)
• Scientific Symposia
• ATS Clinical Practice Guidelines: Clinical Practice on The Cutting Edge - Presented by Ganesh Raghu, MD (ATS 2019)
• ATS Clinical Practice Guidelines: Clinical Practice on The Cutting Edge - Presented by Ganesh Raghu, MD (ATS 2018)
• ECRI Institute Guideline Summary and Scorecard
• Pre-registration required for free access.
• Press Release
• New Guideline Aids in Diagnosing Idiopathic Pulmonary Fibrosis (Aug. 31, 2018)
• Patient and Family Education
• Idiopathic Pulmonary Fibrosis (2017)
• IPF General Information
• Guideline Central Pocket Guide
• Podcasts
• Clinician to Clinician: an AnnalsATS Podcast - Idiopathic Pulmonary Fibrosis, June 2019 (Dr. Ganesh Raghu and Dr. Kevin Wilson join Dr. Gregory Tino)
• Out of the Blue: A AJRCCM Podcast - Diagnosis of IPF Clinical Practice Guideline: Part 1, Oct. 11, 2018 (Dr. Ganesh Raghu and Dr. Kevin Wilson join Nitin Seam)
• Out of the Blue: A AJRCCM Podcast - Diagnosis of IPF Clinical Practice Guideline: Part 2, Oct. 25, 2018 (Dr. Ganesh Raghu and Dr. Kevin Wilson join Nitin Seam)
• Twitter Chat (Sep. 24, 2018)
• Clinician Video

Complementary Materials

• Other Related Guidelines
• Raghu G, Rochwerg B, Zhang Y, Cuello Garcia CA, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015; 192(2): e3-e19.
• Executive Summary
• Full-Length Version
• Evidence Tables
• Evidence-to-Decision Tables
• Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official ATS clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2016; 185(9): 1004-1014.
• Guideline
• Online Supplement
• Raghu G, Collard HR. Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 784-824.
• Full-Length Version
• Online Supplement
• Related Statements and Workshop Reports
• White ES, Borok Z, Brown KK, Eickelberg O, Guenther A, Jenkins RG, et al.  An ATS official research statement: future directions in lung fibrosis research. Am J Respir Crit Care Med 2016; 193(7):792-800.
• Travis WD, Costabel U, Hansell DM, King Jr TE, Lynch DA, Nicholson AG, et al.  An official ATS/ERS statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188(6):733-748.
• Related Editorials and Letters to the Editor
• Ravaglia C, Tomassetti S and Poletti V.  New idiopathic pulmonary fibrosis guidelines: are cryobiopsy and surgery competitive in clinical practice?. Am J Respir Crit Care Med 2019; 199(5): 666-667.
• Richeldi L, Wilson KC, Raghu G.  Diagnosing idiopathic pulmonary fibrosis: bridging recommendations made by experts serving different societies. Eur Resp J 2018; 52(3):1801485.
• General Reviews and Updates
• Schupp JC, Kaminski N.  Towards early detection of IPF. Am J Respir Crit Care Med 2019. (In Press)
• Nathan SD.  Nintedanib and sildenafil in patients with idiopathic pulmonary fibrosis: echoes of the past, lessons for the future. Am J Respir Crit Care Med 2019. (In Press)
• Walsh SLF, Lederer DJ, Ryerson CJ, Kolb M, Maher TM, Nusser R.  Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2019. (In Press)
• Dove EP, Olson AL and Glassberg MK.  Trends in IPF-related mortality in the united states: 2000-2017. Am J Respir Crit Care Med 2019. (In Press)
• Sgalla G, Kulkarni T, Antin-Ozerki D, Thannickal VJ, Richeldi L.  Update in pulmonary fibrosis 2018. Am J Respir Crit Care Med 2019; 200(3):292-300.
• Wilson KC, Schoenberg N, Raghu G.  IPF guideline recommendations: need for adherence to institute of medicine methodology?. Ann Am Thorac Soc 2019; 16(6):681-686.
• Goobie GC, Guler SA, Johannson KA, Fisher JH, Ryerson CJ.  YouTube videos as a source of misinformation on idiopathic pulmonary fibrosis.  Ann Am Thorac Soc 2019; 16(5):572–579.
• Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, et al.  Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am J Respir Crit Care Med 2016; 194:265–275.
• Related Press Release
• New Guidelines for the Treatment of IPF Released by Leading Respiratory Societies (Jul. 15, 2015)
• Related Patient and Family Education
• Pulmonary Fibrosis Foundation - CME/CEU Library
• Guideline Central Pocket Guide - Treatment of IPF
• Related Webinars
• Nintedanib and Sildenafil in Idiopathic Pulmonary Fibrosis Webinar (Jan. 18, 2019) - Presenter: John Swisher